XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenues:    
Product sales $ 4,045,637 $ 3,861,205
Product sales - related parties and subsidiaries 0 60,626
Manufacturing service 0 43,409
Consulting services, related parties 0 2,100
Total revenues 4,045,637 3,967,340
Cost of sales 5,050,570 3,724,498
Cost of sales, related parties 210,900 3,796
Total cost of sales 5,261,470 3,728,294
Gross profit from operations (1,215,833) 239,046
Operating expenses:    
General and administrative 5,636,166 2,639,285
General and administrative, related parties 541,886 606,842
Sales and marketing 1,301,995 858,295
Sales and marketing, related parties 116,402 26,660
Expensing (recovery) of related party debt (444,962) 1,470,522
Impairment loss on long-lived assets 4,874,917 1,721,663
Total operating expenses 12,026,404 7,323,268
Operating loss (13,242,237) (7,084,222)
Other income (expense):    
Interest expense, net (269,963) (47,265)
Other expense, net 69,979 (3,470)
Income before income taxes (13,442,221) (7,134,957)
Provision for income taxes 0 0
Net loss (13,442,221) (7,134,957)
Net loss attributable to non-controlling interests (316,140) (131,123)
Net loss attributable to Hempacco Co., Inc. $ (13,126,081) $ (7,003,834)
Basic and dilutive earnings per share: $ (4.70) $ (3.27)
Shares used in calculation of earnings per share: 2,795,716 2,139,386